Ayrton Drug Manufacturing Ltd. announced earnings results for the first quarter ended September 30, 2019. For the first quarter, the company announced sales was GHS 5.605 million compared to GHS 6.566 million a year ago. Operating loss was GHS 748,726 compared to operating Income of GHS 1.230 million a year ago. Net loss was GHS 1.252 million compared to net income of GHS 684,450 a year ago. Basic loss per share was GHS 0.0058 compared to basic earnings per share of GHS 0.01682 a year ago.